Ouathek Ouerfelli

Sloan-Kettering Inst Can Research

$6,457,753

Attributed

$6,457,753

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $861.1K · FY2014–25

$1M$750K$500K$250K$0

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$6,457,753 · 3

By mechanism

P30$4,798,016 · 2

R50$1,659,737 · 1

Top collaborators

No co-investigators on record.

Most similar at Sloan-Kettering Inst Can Research

Same institution · by research overlap

Others in their field

Top investigators on “Therapeutic Agents”

David Heimbrook · Leidos Biomedical Research, Inc.$386,032,874
Gregory H Reaman · National Childhood Cancer Foundation$247,684,034
Leonard Freedman · Leidos Biomedical Research, Inc.$239,520,687
Sharon A Nachman · Johns Hopkins University$213,337,729
Glenda E Gray · Wits Health Consortium (Pty), Ltd$208,842,121
Joseph J. Eron · Univ Of North Carolina Chapel Hill$197,687,122

Research focus

Therapeutic AgentsChemical SynthesisChemistryOrganic SynthesisServicesPreclinical StudyMedicinePreventionCancer DetectionHuman ResourcesResearch PersonnelBiologyCommunitiesPharmaceutical PreparationsMissionPharmaceutical ChemistryCore FacilityCancer Center Support GrantMemorial Sloan-Kettering Cancer CenterProceduresAndrogen ReceptorCollaborative EnvironmentFundingFda Approved